Sarepta's Duchenne gene therapy misses main goal in study-November 2024-www.financetom.com

Sarepta's Duchenne gene therapy misses main goal in study

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Sarepta's Duchenne gene therapy misses main goal in study

Nov 3, 2025 1:36 PM

Nov 3 (Reuters) - Sarepta said on Monday that

its late-stage study testing two gene-targeted therapies for

Duchenne muscular dystrophy did not meet the main goal.

Previous page： Goldman's China co-head Morse to retire, Bloomberg News reports Next page： BlackBerry Working With AMD to Create Robotics Platform

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Goldman's China co-head Morse to retire, Bloomberg News reports

Apr 9, 2024

April 9 (Reuters) - Goldman Sachs Group's ( GS ) co-head of its China business E.G. Morse will retire after 16 years at the company, Bloomberg News said on Tuesday, citing an internal memo. ...

BlackBerry Working With AMD to Create Robotics Platform

Apr 9, 2024

03:37 AM EDT, 04/09/2024 (MT Newswires) -- BlackBerry (BB) on Tuesday unveiled a new precision robotics platform in collaboration with chipmaker AMD (AMD). The collaboration, called BlackBerry QNX, will provide a reasonably priced robotics platform with enhanced performance, reliability, and scalability for robotic applications in industry and medicine, according to the companies. The platform combines BlackBerry's real-time software tools with...

Former Tesla CEO says it is a 'shame' company is cancelling low-cost car plans

Apr 9, 2024

HONG KONG, April 9 (Reuters) - A Tesla founder and former chief executive said on Tuesday it was a shame to hear that the automaker was scrapping its low-cost car plans amid fierce competition in China. Martin Eberhard was speaking at the HSBC Global Investment Summit in Hong Kong. On Friday, Reuters reported that Tesla was cancelling its long-promised inexpensive...

Aviva completes takeover of AIG's UK life insurance business

Apr 9, 2024

LONDON, April 9 (Reuters) - British insurer Aviva said on Tuesday it had completed the 453 million pound ($574 million) acquisition of AIG's UK life insurance business, sealing the largest takeover under CEO Amanda Blanc to date. Aviva announced the deal in September. The company is buying the unit - known as AIG Life UK - from Corebridge Financial Inc...